Get started
Author

Emre Demirci

Pre-therapeutic dosimetry of normal organs and tissues of 177Lu-PSMA-617 prostate-specific membrane antigen (PSMA) inhibitor in patients with castration-resistant prostate cancer
2015 · Levent Kabasakal, Mohammad AbuQbeitah, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 211
Normal distribution pattern and physiological variants of 68Ga-PSMA-11 PET/CT imaging
2016 · Emre Demirci, Onur Erdem Sahin, et al. · Nuclear Medicine Communications · 169
Comparison of 68Ga-DOTATATE and 68Ga-DOTANOC PET/CT imaging in the same patient group with neuroendocrine tumours
2012 · Levent Kabasakal, Emre Demirci, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 153
Can SUVmax values of Ga-68-PSMA PET/CT scan predict the clinically significant prostate cancer?
2018 · Emre Demirci, Levent Kabasakal, et al. · Nuclear Medicine Communications · 148
68Ga-PSMA PET/CT imaging of metastatic clear cell renal cell carcinoma
2014 · Emre Demirci, Meltem Ocak, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 140
Evaluation of PSMA PET/CT imaging using a 68Ga-HBED-CC ligand in patients with prostate cancer and the value of early pelvic imaging
2015 · Levent Kabasakal, Emre Demirci, et al. · Nuclear Medicine Communications · 138
The accuracy of 68Ga-PSMA PET/CT in primary lymph node staging in high-risk prostate cancer
2017 · Can Öbek, Tünkut Doğanca, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 108
Lu-177-PSMA-617 Prostate-Specific Membrane Antigen Inhibitor Therapy in Patients with Castration-Resistant Prostate Cancer: Stability, Bio-distribution and Dosimetry
2017 · Levent Kabasakal, Türkay Toklu, et al. · Molecular Imaging and Radionuclide Therapy · 87
PDF
Imaging Cancer-Associated Fibroblasts (CAFs) with FAPi PET
2022 · Laura Gilardi, Lighea Simona Airò Farulla, et al. · Biomedicines · 78
PDF
177Lu-DOTATATE therapy in patients with neuroendocrine tumours including high-grade (WHO G3) neuroendocrine tumours
2018 · Emre Demirci, Levent Kabasakal, et al. · Nuclear Medicine Communications · 65
The role of PSMA PET/CT imaging in restaging of prostate cancer patients with low prostate-specific antigen levels
2016 · Levent Kabasakal, Emre Demirci, et al. · Nuclear Medicine Communications · 40
Clinical Experience with [225Ac]Ac-PSMA Treatment in Patients with [177Lu]Lu-PSMA–Refractory Metastatic Castration-Resistant Prostate Cancer
2023 · Nalan Alan-Selcuk, Gamze Beydagi, et al. · Journal of Nuclear Medicine · 37
PDF
Post-therapy imaging of 225Ac-DOTATATE treatment in a patient with recurrent neuroendocrine tumor
2020 · Meltem Ocak, Türkay Toklu, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 33
Evaluation and comparison of Ga-68 DOTA-TATE and Ga-68 DOTA-NOC PET/CT imaging in well-differentiated thyroid cancer
2013 · Meltem Ocak, Emre Demirci, et al. · Nuclear Medicine Communications · 30
Initial Findings on the Use of [225Ac]Ac-DOTATATE Therapy as a Theranostic Application in Patients with Neuroendocrine Tumors
2023 · Emre Demirci, Nalan Alan Selçuk, et al. · Molecular Imaging and Radionuclide Therapy · 29
PDF
Interobserver and intraobserver agreement on prostate-specific membrane antigen PET/CT images according to the miTNM and PSMA-RADS criteria
2020 · Emre Demirci, Reşit Akyel, et al. · Nuclear Medicine Communications · 27
Comparison of 68Ga‐PSMA PET/CT and mp‐MRI in regard to local staging for prostate cancer with histopathological results: A retrospective study
2022 · Taha Ucar, Nesrin Gunduz, et al. · The Prostate · 24
The role of 68Ga-DOTA-TATE PET/CT scanning in the evaluation of patients with multiple myeloma
2016 · Kerim Sonmezoglu, Betul Vatankulu, et al. · Nuclear Medicine Communications · 21
ESTIMATION OF THE ORGAN ABSORBED DOSES AND EFFECTIVE DOSE FROM 68Ga-PSMA-11 PET SCAN†
2018 · Emre Demirci, Türkay Toklu, et al. · Radiation Protection Dosimetry · 17
Preclinical Evaluation of 18 F-ML-10 to Determine Timing of Apoptotic Response to Chemotherapy in Solid Tumors
2017 · Emre Demirci, Rafay Ahmed, et al. · Molecular Imaging · 17
PDF
Comparison of Ga-68 DOTA-TATE and Ga-68 DOTA-LAN PET/CT imaging in the same patient group with neuroendocrine tumours
2013 · Emre Demirci, Meltem Ocak, et al. · Nuclear Medicine Communications · 15
Clinical Impact of Lower-Limb Imaging in 68Ga-PSMA PET/CT for Patients with Prostate Cancer
2019 · Duygu Has Simsek, Yasemin Sanli, et al. · Journal of Nuclear Medicine Technology · 11
PDF
Impact of 68Ga-FAPi PET/CT on Staging or Restaging Digestive System Tumors in Patients with Negative or Equivocal 18F-FDG PET/CT Findings
2025 · Nalan Alan Selçuk, Gamze Beydağı, et al. · Molecular Imaging and Radionuclide Therapy · 10
PDF
The Role of 68GA-PSMA PET/CT Scan In Patients with Prostate Adenocarcinoma who Underwent Radical Prostatectomy.
2020 · Mehmet Hamza Gultekin, Emre Demirci, et al. · Urology journal./Urology jornal. · 10
PDF
Radiolabeled FAP inhibitors as new pantumoral radiopharmaceuticals for PET imaging: a pictorial essay
2022 · Lighea Simona Airò Farulla, Emre Demirci, et al. · Clinical and Translational Imaging · 9
Works count: 66
Citation count: 1,702
H-index: 18
I10-index: 24
Year
Topic
Type